Joseph Michael Fitzgerald is EVP & Group Pres, Cardiology of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 168,042 shares of BSX, which is worth approximately $17.3 Million. The most recent transaction as insider was on Feb 10, 2021, when has been sold 17,995 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K
5.78% 3M change
8.0% 12M change
Total Value Held $17.3 Million

Joseph Michael Fitzgerald Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2021
BUY
Grant, award, or other acquisition
-
17,995 Added 6.72%
249,598 Common Stock
Feb 08 2021
SELL
Bona fide gift
-
3,040 Reduced 1.3%
231,603 Common Stock
Jan 01 2021
SELL
Payment of exercise price or tax liability
$489,603 $35.95 p/Share
13,619 Reduced 5.49%
234,628 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
27,199 Added 9.87%
248,247 Common Stock
JMF

Joseph Michael Fitzgerald

EVP & Group Pres, Cardiology
Marlborough, MA

Track Institutional and Insider Activities on BSX

Follow BOSTON SCIENTIFIC CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX